Evidence map›Paper›PMID 33145287›Full record

ArticleAnnals of translational medicine2020

Development and formulation of the classification criteria for osteoarthritis.

Cibo Huang, Zhiyi Zhang, Yaolong Chen, Yue Zhang, Dan Xing, Like Zhao, Jianhao Lin, Yifang Mei, Hsiao-Yi Lin, Yi Zheng and 27 more

Erratum issuedAbstract read
In one paragraph

Article in Annals of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Osteoarthritis.Nature reviews. Disease primers · 2025
    Review
  9. The Role of MicroRNAs in the Pathophysiology of Osteoarthritis.International journal of molecular sciences · 2024
    Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

37 authors.

Cibo HuangDepartment of Rheumatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Zhiyi ZhangDepartment of Rheumatology, The First Affiliated Hospital, Harbin Medical University, Harbin, China.
Yaolong ChenEvidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Yue ZhangArthritis Clinic & Research Center, Peking University People's Hospital, Beijing, China.
Dan XingArthritis Clinic & Research Center, Peking University People's Hospital, Beijing, China.
Like ZhaoDepartment of Rheumatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Jianhao LinArthritis Clinic & Research Center, Peking University People's Hospital, Beijing, China.
Yifang MeiDepartment of Rheumatology, The First Affiliated Hospital, Harbin Medical University, Harbin, China.
Hsiao-Yi LinVeterans General Hospital, Taipei and National Yang-Ming Medical University, Taipei, Taiwan.
Yi ZhengDepartment of Rheumatology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Wei-Chung TsaiDepartment of Internal Medicine, Kaohsiung Medical College, Kaohsiung City, Taiwan.
Shengyun LiuDepartment of Rheumatology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Quan JiangDepartment of Rheumatology and Immunology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Yi LiuDepartment of Rheumatology, West China Hospital, Sichuan University, Chengdu, China.
Jinwei ChenDepartment of Rheumatology, Second Xiangya Hospital, Central South University, Changsha, China.
Zhizhong YeShenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, China.
Min ChenDepartment of Rheumatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Yingjuan ChenDepartment of Rheumatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Cong-Qiu ChuDivision of Arthritis and Rheumatic Diseases, Oregon Health & Science University and VA Portland Health Care System, Portland, OR, USA.
Ming GaoDepartment of Rheumatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Lan HeDepartment of Rheumatology and Immunology, the First Hospital of Xi'an Jiaotong University, Xi'an, China.
Jin LinDepartment of Rheumatology, First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Lijun WuDepartment of Rheumatology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumchi, China.
Jianhua XuDepartment of Rheumatology and Immunology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
Pinting YangDepartment of Rheumatology and Immunology, the First Affiliated Hospital of China Medical University, Beijing, China.
Xuewu ZhangDepartment of Rheumatology, Peking University People's Hospital, Beijing, China.
Qing JiangDepartment of Osteoarthrosis, Affiliated Drum Tower Hospital, Nanjing University Medical College, Nanjing, China.
Guanghua LeiDepartment of Orthopedics, Xiangya Hospital, Central South University, Changsha, China.
Mengtao LiDepartment of Rheumatology, Peking Union Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Wanling YangShenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, China.
Xin GuBeijing Hospital Rehabilitation Medicine, Beijing, China.
Yixin ZhouDepartment of Orthopedics, Beijing Jishuitan Hospital, Beijing, China.
Dongyi HeDepartment of Rheumatology and Immunology, Shanghai Guanghua Hospital, Shanghai, China.
Wei LiuDepartment of Rheumatology and Immunology, Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Weiya ZhangAcademic Rheumatology, University of Nottingham, Nottingham, UK.
Changhai DingUniversity of Tasmania, Tasmania, Australia.
Xiaofeng ZengDepartment of Rheumatology, Peking Union Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe classification criteria of osteoarthritis (OA) is lack of the support of relevant research evidence and there is no standardized protocol for detailed steps of the development or clinical verification of classification criteria has yet been established. This study aims to describe the development process of the Categorization of Osteoarthritis CHecklist (COACH), which is designed to choose the precise treatment option for patients with OA.

methodsA multidisciplinary panel was established to gather opinions. We conducted questionnaire survey and literature review to generate and COACH Panel members were invited to review the drafted classification criteria and optimize classification criteria. The final list of items was discussed and reached the agreement by the core group of the panel.

resultsThirty-six experts participated in COACH Panel including rheumatologist (80.6%; 29/36), orthopedist (13.9%; 5/36), methodologist (2.8%; 1/36) and rehabilitation physician (2.8%; 1/36) for classification factors generating and optimizing. The main body of the final classification criteria consists of six types of OA pathogenesis, eight types of medical findings (which can be grouped into two categories), and six types of the location. The final criteria include load-based type, structure-based type, inflammation-based type, metabolic-based type, systemic factor based type and mixed type.

conclusionsCOACH can better help clinicians quickly classify OA patients and help to choose the best treatment option from the aspects of types, findings and locations. What's more, the classification criteria are also helpful to promote the basic medical research and targeted prevention of OA.

Indexed as

classificationclassification factorsliterature reviewOsteoarthritis (OA)survey

Identifiers

PMID33145287
PMCPMC7575945

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.